Dashboard
Manage Tickers

FHTXFoghorn Therapeutics Inc.

Nasdaq foghorntx.com


$ 9.97 $ 0.09 (0.91 %)    

Tuesday, 17-Sep-2024 15:22:45 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.85 $ -3.12 (-0.66 %)
DIA $ 416.65 $ -1.34 (-0.32 %)
SPY $ 562.17 $ -2.96 (-0.52 %)
TLT $ 100.92 $ -0.47 (-0.46 %)
GLD $ 237.27 $ -0.71 (-0.3 %)
$ 9.26
$ 9.88
$ 10.00 x 100
-- x --
$ 9.39 - $ 10.09
$ 2.70 - $ 10.01
179,447
na
512.34M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 03-07-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-10-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-11-2021 03-31-2021 10-Q
15 03-18-2021 12-31-2020 10-K
16 12-04-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jefferies-initiates-coverage-on-foghorn-therapeutics-with-buy-rating-announces-price-target-of-18
Jefferies Initiates Coverage On Foghorn Th...
09/03/2024 12:44:42

Jefferies analyst Kelly Shi initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Buy rating and announces Price T...

why-nikola-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Nikola Shares Are Trading Lower By Aro...
08/19/2024 17:37:46

zim-integrated-shipping-services-posts-upbeat-earnings-joins-fubotv-foghorn-therapeutics-and-other-big-stocks-moving-higher-on-monday
ZIM Integrated Shipping Services Posts Upb...
08/19/2024 14:25:31

evercore-isi-group-initiates-coverage-on-foghorn-therapeutics-with-outperform-rating-announces-price-target-of-20
Evercore ISI Group Initiates Coverage On F...
08/19/2024 13:56:40

Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Outperform ra...

hc-wainwright--co-reiterates-buy-on-foghorn-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Fogh...
08/12/2024 10:27:14

HC Wainwright & Co. analyst Andrew Fein reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Buy and maintains $20 price...

wedbush-reiterates-outperform-on-foghorn-therapeutics-maintains-13-price-target
Wedbush Reiterates Outperform on Foghorn T...
08/09/2024 14:04:20

Wedbush analyst Robert Driscoll reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Outperform and maintains $13 price target.

foghorn-therapeutics-q2-2024-gaap-eps-045-beats-047-estimate-sales-6888m-beat-6094m-estimate-cash-cash-equivalents-and-short-term-investments-of-2852m-as-of-june-30-2024-and-extends-expected-cash-runway-into-2027
Foghorn Therapeutics Q2 2024 GAAP EPS $(0....
08/08/2024 12:25:38

foghorn-therapeutics-says-flagship-pioneering-raised-36b-to-to-support-the-creation-and-development-of-an-estimated-25-breakthrough-companies-in-human-health
Foghorn Therapeutics Says Flagship Pioneer...
07/10/2024 10:18:15

foghorn-prices-110m-registered-direct-offering-of-12743039-common-stock-at-a-price-of-551-per-share-and-pre-funded-warrants-to-purchase-up-to-an-aggregate-of-7220794-shares-of-its-common-stock-at-a-price-of-55099-per-pre-funded-warrant
Foghorn Prices $110M Registered Direct Off...
05/20/2024 12:02:33

Foghorn Therapeutics Inc. ("Foghorn") (NASDAQ:FHTX) today announced the pricing of a registered direct offering of 12,7...

hc-wainwright--co-reiterates-buy-on-foghorn-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Fogh...
05/07/2024 10:49:39

HC Wainwright & Co. analyst Andrew Fein reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Buy and maintains $20 price...

hc-wainwright--co-reiterates-buy-on-foghorn-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Fogh...
05/01/2024 11:26:48

HC Wainwright & Co. analyst Andrew Fein reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Buy and maintains $20 price...

foghorn-therapeutics-has-appointed-kristian-humer-as-chief-financial-officer
Foghorn Therapeutics Has Appointed Kristia...
04/16/2024 11:09:46

wedbush-reiterates-outperform-on-foghorn-therapeutics-maintains-13-price-target
Wedbush Reiterates Outperform on Foghorn T...
04/10/2024 12:04:19

Wedbush analyst Robert Driscoll reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Outperform and maintains $13 price target.

hc-wainwright--co-reiterates-buy-on-foghorn-therapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Fogh...
04/10/2024 10:18:33

HC Wainwright & Co. analyst Andrew Fein reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Buy and maintains $20 price...

foghorn-therapeutics-presents-new-preclinical-data-on-fhd-909-says-fhd-909-demonstrated-favorable-tolerability-and-dose-dependent-single-agent-activity-in-brg1-mutated-cancers-preclinically
Foghorn Therapeutics Presents New Preclini...
04/09/2024 20:34:40

wedbush-reiterates-outperform-on-foghorn-therapeutics-maintains-13-price-target
Wedbush Reiterates Outperform on Foghorn T...
03/08/2024 15:08:58

Wedbush analyst Robert Driscoll reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Outperform and maintains $13 price target.

foghorn-therapeutics-q4-earnings-insights
Foghorn Therapeutics: Q4 Earnings Insights
03/07/2024 14:05:06

foghorn-therapeutics-reports-fy23-collaboration-revenue-of-342m-vs-192m-a-year-ago
Foghorn Therapeutics Reports FY23 Collabor...
03/07/2024 12:16:50

foghorn-therapeutics-to-present-new-preclinical-data-at-2024-aacr-annual-meeting-reflecting-advances-with-multiple-potential-first-in-class-medicines-including-the-selective-inhibitor-of-brm-fhd-909
Foghorn Therapeutics To Present New Precli...
03/05/2024 21:51:19

Poster presentation of FHD-909, a first-in-class oral BRM selective inhibitor, highlighting preclinical efficacy and safety in ...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
02/08/2024 17:31:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION